vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and FIRST UNITED CORP (FUNC). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $23.2M, roughly 1.9× FIRST UNITED CORP). FIRST UNITED CORP runs the higher net margin — 24.9% vs -23.3%, a 48.2% gap on every dollar of revenue. On growth, FIRST UNITED CORP posted the faster year-over-year revenue change (11.9% vs 7.0%). Over the past eight quarters, FIRST UNITED CORP's revenue compounded faster (11.5% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

AMRN vs FUNC — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.9× larger
AMRN
$45.1M
$23.2M
FUNC
Growing faster (revenue YoY)
FUNC
FUNC
+4.9% gap
FUNC
11.9%
7.0%
AMRN
Higher net margin
FUNC
FUNC
48.2% more per $
FUNC
24.9%
-23.3%
AMRN
Faster 2-yr revenue CAGR
FUNC
FUNC
Annualised
FUNC
11.5%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
FUNC
FUNC
Revenue
$45.1M
$23.2M
Net Profit
$-10.5M
$5.8M
Gross Margin
Operating Margin
35.5%
32.9%
Net Margin
-23.3%
24.9%
Revenue YoY
7.0%
11.9%
Net Profit YoY
33.0%
-6.6%
EPS (diluted)
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
FUNC
FUNC
Q1 26
$45.1M
Q4 25
$49.2M
$23.2M
Q3 25
$49.7M
$22.7M
Q2 25
$72.7M
$21.8M
Q1 25
$42.0M
$20.9M
Q4 24
$62.3M
$20.8M
Q3 24
$42.3M
$20.3M
Q2 24
$67.5M
$20.1M
Net Profit
AMRN
AMRN
FUNC
FUNC
Q1 26
$-10.5M
Q4 25
$-1.2M
$5.8M
Q3 25
$-7.7M
$6.9M
Q2 25
$-14.1M
$6.0M
Q1 25
$-15.7M
$5.8M
Q4 24
$-48.6M
$6.2M
Q3 24
$-25.1M
$5.8M
Q2 24
$1.5M
$4.9M
Gross Margin
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
FUNC
FUNC
Q1 26
35.5%
Q4 25
-12.9%
32.9%
Q3 25
-22.4%
40.6%
Q2 25
-22.0%
36.5%
Q1 25
-39.9%
36.8%
Q4 24
-84.3%
39.2%
Q3 24
-59.5%
38.0%
Q2 24
-0.8%
32.5%
Net Margin
AMRN
AMRN
FUNC
FUNC
Q1 26
-23.3%
Q4 25
-2.5%
24.9%
Q3 25
-15.6%
30.6%
Q2 25
-19.4%
27.5%
Q1 25
-37.4%
27.7%
Q4 24
-78.0%
29.8%
Q3 24
-59.4%
28.5%
Q2 24
2.3%
24.5%
EPS (diluted)
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
$0.00
$0.89
Q3 25
$-0.02
$1.07
Q2 25
$-0.03
$0.92
Q1 25
$-0.04
$0.89
Q4 24
$-0.12
$0.95
Q3 24
$-0.06
$0.89
Q2 24
$0.00
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
FUNC
FUNC
Cash + ST InvestmentsLiquidity on hand
$307.8M
$131.6M
Total DebtLower is stronger
$95.9M
Stockholders' EquityBook value
$203.6M
Total Assets
$645.8M
$2.1B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
FUNC
FUNC
Q1 26
$307.8M
Q4 25
$302.6M
$131.6M
Q3 25
$286.6M
$95.2M
Q2 25
$298.7M
$79.1M
Q1 25
$281.8M
$84.4M
Q4 24
$294.2M
$78.3M
Q3 24
$305.7M
$62.4M
Q2 24
$306.7M
$45.1M
Total Debt
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
$95.9M
Q3 25
$95.9M
Q2 25
$120.9M
Q1 25
$120.9M
Q4 24
$120.9M
Q3 24
$120.9M
Q2 24
$70.9M
Stockholders' Equity
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
$459.3M
$203.6M
Q3 25
$458.9M
$199.1M
Q2 25
$464.9M
$191.1M
Q1 25
$473.7M
$183.7M
Q4 24
$486.2M
$179.3M
Q3 24
$531.4M
$174.0M
Q2 24
$551.9M
$164.2M
Total Assets
AMRN
AMRN
FUNC
FUNC
Q1 26
$645.8M
Q4 25
$670.8M
$2.1B
Q3 25
$659.8M
$2.0B
Q2 25
$670.1M
$2.0B
Q1 25
$655.7M
$2.0B
Q4 24
$685.3M
$2.0B
Q3 24
$750.6M
$1.9B
Q2 24
$799.9M
$1.9B
Debt / Equity
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
0.47×
Q3 25
0.48×
Q2 25
0.63×
Q1 25
0.66×
Q4 24
0.67×
Q3 24
0.70×
Q2 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
FUNC
FUNC
Operating Cash FlowLast quarter
$19.4M
Free Cash FlowOCF − Capex
$15.4M
FCF MarginFCF / Revenue
66.3%
Capex IntensityCapex / Revenue
17.1%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$22.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
$15.3M
$19.4M
Q3 25
$-12.7M
$1.5M
Q2 25
$16.6M
$995.0K
Q1 25
$-12.5M
$7.0M
Q4 24
$-13.3M
$22.3M
Q3 24
$-2.4M
$2.3M
Q2 24
$-2.7M
$7.2M
Free Cash Flow
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
$15.4M
Q3 25
$168.0K
Q2 25
$706.0K
Q1 25
$6.4M
Q4 24
$20.4M
Q3 24
$588.0K
Q2 24
$7.0M
FCF Margin
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
66.3%
Q3 25
0.7%
Q2 25
3.2%
Q1 25
30.5%
Q4 24
98.1%
Q3 24
2.9%
Q2 24
35.1%
Capex Intensity
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
17.1%
Q3 25
5.9%
Q2 25
1.3%
Q1 25
2.8%
Q4 24
9.3%
Q3 24
8.4%
Q2 24
0.6%
Cash Conversion
AMRN
AMRN
FUNC
FUNC
Q1 26
Q4 25
3.35×
Q3 25
0.22×
Q2 25
0.17×
Q1 25
1.20×
Q4 24
3.60×
Q3 24
0.40×
Q2 24
-1.81×
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

Related Comparisons